19 September 2024
Dental innovation: Actival and CSEM launch 3D antibacterial aligners
Actival is redefining dental alignment with its innovative 'Active Aligners.' They feature patented 3D-printed microchannel technology developed by CSEM.
Life sciences
Revolutionizing treatments. Optimizing outcomes.
Technology is opening new possibilities for patient care and operational efficiency across the life sciences sector. Our expertise, insight and technological capabilities are helping companies take full advantage.
Life sciences companies’ central role in drug pricing and access to medicines puts them on the frontline of societal challenges like aging populations, disease outbreaks, increasing incidence of cancer and cardiac disorders, and antibiotic resistance. Companies are also having to adapt to a dynamically changing clinical, regulatory, and business landscape. Creating the right solutions involves combining technology with innovative thinking and a data-driven strategy. That’s where CSEM is helping the industry meet the evolving needs of patients around the world.
High-impact biotechnology
Investment in technology is a priority across the healthcare sector. New biotechnologies are allowing clinicians to meet the needs of patients and their families more effectively. They are forming the basis of new medicines, diagnostics, and tissue-engineered products as well as gene and cell therapies.
We are using our expertise in miniaturization, integration, and microengineering to develop new devices, tools, and systems for toxicology, pharmacology, diagnostics, and regenerative medicine. They are providing enhanced performance as well as deepening our understanding of how our body is working and how it is affected by different drugs and chemicals.
Precision engineered microtechnology and digitalization
CSEM technologies aim to improve the quality of life of patients and make new treatments accessible for all. Our technology platforms are addressing the evolving needs of the life sciences field using automated cell technologies, biomonitoring, and artificial intelligence.
From concept to prototyping and validation in biosafety level II laboratories, CSEM helps industry to innovate and develop new products across the following application domains:
· Micro physiological systems and organoids
· Point-of-care diagnostics
· Labs of the future
Meet our happy customers
Alexios Tzannis
Business Development Manager Life Sciences
CSEM was really open and flexible, proactively coming up with proposals for addressing the challenge and presenting the results superbly and on time—I can only give compliments about the collaboration.
Related Articles
25 July 2024
CSEM develops a pioneering implant to support reproductive medicine
Swiss-based start-ups Impli and Yalosys, and the technology innovation center CSEM present an implantable biosensor for real-time fertility hormone monitoring.
11 July 2024
Four future start-ups from CSEM could soon revolutionize our daily lives
The ACCELERATE program, an initiative dedicated to supporting and stimulating entrepreneurial innovation in Switzerland, has announced the winners of its 2024 edition. Among the start-up ideas competing this year, four stood out for their potential to transform the Swiss medical, technological, and watchmaking landscape.